Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 7 SUPPL., 2009, Pages

  Gervais, Debra A ^a   Goldberg, S Nahum ^b   Brown, Daniel B ^c   Soulen, Michael C ^d   Millward, Steven F ^e   Rajan, Dheeraj K ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMOEMBOLIZATION; COLORECTAL CARCINOMA; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MEDICAL SOCIETY; METASTASIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT INDICATION;

EID: 67649819132     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.04.029     Document Type: Article

References (60)

1. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (2004) S27-S34
2. El-Serag H.B. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35 (2002) S72-S78
3. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
4. Harmon K.E., Ryan Jr. J.A., Biehl T.R., and Lee F.T. Benefits and safety of hepatic re-section for colorectal metastases. Am J Surg 177 (1999) 402-404
5. Liu C.L., and Fan S.T. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 173 (1997) 358-365
6. Ebara M., Okabe S., Kita K., et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43 (2005) 458-464
7. Huang G.T., Lee P.H., Tsang Y.M., et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242 (2005) 36-42
8. Lencioni R.A., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
9. Livraghi T., Goldberg S.N., Lazzaroni S., Meloni F., Solbiati L., and Gazelle G.S. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210 (1999) 655-661
10. Chen M., Li J., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243 (2006) 321-328
11. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-827
12. Yamakado K., Nakatsuka A., Akeboshi M., and Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 14 (2003) 1183-1186
13. Hinshaw J.L., Laeseke P.F., Winter T.C., Kliewer M.A., Fine J.P., and Lee F.T. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol 186 (2006) 306-310
14. Goldberg S.N., Hahn P.F., Tanabe K.K., et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 9 (1998) 101-111
15. de Baere T., Bessoud B., Dromain C., et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 178 (2002) 53-59
16. Lu D.S., Raman S.S., Limanond P., et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14 (2003) 1267-1274
17. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214 (2000) 761-768
18. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
19. Buscarini L., Buscarini E., Di Stasi M., Vallisa D., Quaretti P., and Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11 (2001) 914-921
20. Chen M.H., Yang W., Yan K., et al. Large liver tumors: protocol for radio-frequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 232 (2004) 260-271
21. Choi D., Lim H.K., Kim M.J., et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230 (2004) 135-141
22. Elias D., De Baere T., Smayra T., Ouellet J.F., Roche A., and Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after Hepatectomy. Br J Surg 89 (2002) 752-756
23. Giovannini M., Moutardier V., Danisi C., Bories E., Pesenti C., and Delpero J.R. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients. J GI Surg 7 (2003) 791-796
24. Giorgio A., Tarantino L., de Stefano G., et al. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 181 (2003) 479-484
25. Hori T., Nagata K., Hasuike S., et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38 (2003) 977-981
26. Izumi N., Asahina Y., Noguchi O., et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 91 (2001) 949-956
27. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 127 (2004) 1714-1723
28. Omata M., Tateishi R., Yoshida H., and Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127 (2004) S159-S166
29. Poon R.T., Ng K.K., Lam C.M., Ai V., Yuen J., and Fan S.T. Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 139 (2004) 281-287
30. Sala M., Llovet J.M., Vilana R., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360
31. Shibata T., Iimuro Y., Yamamoto Y., et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223 (2002) 331-337
32. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma an analysis of 1000 cases. Cancer 103 (2005) 1201-1209
33. Yamanaka Y., Shiraki K., Miyashita K., et al. Risk factors for the recurrence of hepatocellular carcinoma after radio-frequency ablation of hepatocellular carcinoma in patients with hepatitis C. World J Gastroenterol 11 (2005) 2174-2178
34. Yu H.C., Cheng J.S., Lai K.H., et al. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 11 (2005) 1439-1444
35. de Baere T., Elias D., Dromain C., et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 175 (2000) 1619-1625
36. Gillams A.R., and Lees W.R. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14 (2004) 2261-2267
37. Livraghi T., Solbiati L., Meloni F., Ierace T., Goldberg S.N., and Gazelle G.S. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection the "test-of-time" approach. Cancer 97 (2003) 3027-3035
38. Oshowo A., Gillams A., Harrison E., Lees W.R., and Taylor I. Comparison of re-section and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90 (2003) 1240-1243
39. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 (2001) 159-166
40. White T.J., Roy-Choudhury S.H., Breen D.J., et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases: initial experience an adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 21 (2004) 314-320
41. Gillams A., Cassoni A., Conway G., and Lees W. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 30 (2005) 435-441
42. Gunabushanam G., Sharma S., Thulkar S., et al. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. J Vasc Interv Radiol 18 (2007) 67-72
43. Lawes D., Chopada A., Gillams A., Lees W., and Taylor I. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl 88 (2006) 639-642
44. Livraghi T., Goldberg S.N., Solbiati L., Meloni F., Ierace T., and Gazelle G.S. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 220 (2001) 145-149
45. Pawlik T.M., Vauthey J.N., Abdalla E.K., Pollock R.E., Ellis L.M., and Curley S.A. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 141 (2006) 537-543
46. Lu D.S.K., Yu N.C., Raman S.S., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41 (2005) 1130-1137
47. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
48. Yao F.Y., Ferrell L., Bass N.M., Bacchetti P., Ascher N.L., and Roberts J.P. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 8 (2002) 765-774
49. Porrett P.M., Peterman H., Rosen M., et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepato-cellular cancer in the current MELD era. Liver Transplantation 12 (2006) 665-673
50. Jaskolka J.D., Asch M.R., Kachura J.R., et al. Needle tract seeding after radio-frequency ablation of hepatic tumors. J Vasc Interv Radiol 16 (2005) 485-491
51. Mazzaferro V., Battiston C., Perrone S., et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240 (2004) 900-909
52. Fontana R.J., Hamidullah H., Nghiem H., et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transplantation 8 (2002) 1165-1174
53. Kitamoto M., Imagawa M., Yamada H., et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 181 (2003) 997-1003
54. Maluccio M., Covey A.M., Gandhi R., et al. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. J Vasc Interv Radiol 16 (2005) 955-961
55. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., and Goldberg S.N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226 (2003) 441-451
56. Shibata T., Yamamoto Y., Yamamoto N., et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 14 (2003) 1535-1542
57. Choi D., Lim H.K., Kim M.J., et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol 184 (2005) 1860-1867
58. Livraghi T., Lazzaroni S., Meloni F., and Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92 (2005) 856-858
59. Giorgio A., Tarantino L., de Stefano G., Coppola C., and Ferraioli G. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center. AJR Am J Roentgenol 184 (2005) 207-211
60. Koffron A.J., Auffenberg G., Kung R., and Abecassis M. Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246 (2007) 385-392